Zimmer Biomet Holdings Stock Piotroski F Score

ZBH Stock  USD 110.73  1.05  0.94%   
This module uses fundamental data of Zimmer Biomet to approximate its Piotroski F score. Zimmer Biomet F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Zimmer Biomet Holdings. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Zimmer Biomet financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out Zimmer Biomet Altman Z Score, Zimmer Biomet Correlation, Zimmer Biomet Valuation, as well as analyze Zimmer Biomet Alpha and Beta and Zimmer Biomet Hype Analysis.
  
As of now, Zimmer Biomet's Debt To Equity is decreasing as compared to previous years. The Zimmer Biomet's current Debt Equity Ratio is estimated to increase to 0.67, while Short and Long Term Debt Total is projected to decrease to under 4.9 B. As of now, Zimmer Biomet's EV To Sales is increasing as compared to previous years. The Zimmer Biomet's current Inventory Turnover is estimated to increase to 1.28, while PTB Ratio is projected to decrease to 1.63.
At this time, it appears that Zimmer Biomet's Piotroski F Score is Strong. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
8.0
Piotroski F Score - Strong
Current Return On Assets

Positive

Focus
Change in Return on Assets

Decreased

Focus
Cash Flow Return on Assets

Positive

Focus
Current Quality of Earnings (accrual)

Improving

Focus
Asset Turnover Growth

Increase

Focus
Current Ratio Change

Increase

Focus
Long Term Debt Over Assets Change

Lower Leverage

Focus
Change In Outstending Shares

Decrease

Focus
Change in Gross Margin

Increase

Focus

Zimmer Biomet Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Zimmer Biomet is to make sure Zimmer is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Zimmer Biomet's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Zimmer Biomet's financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.670.3594
Way Up
Slightly volatile
Gross Profit Margin0.80.7146
Moderately Up
Pretty Stable
Net Debt3.8 B5.7 B
Way Down
Slightly volatile
Total Current Liabilities1.6 B2.5 B
Way Down
Slightly volatile
Non Current Liabilities Total4.8 B6.4 B
Way Down
Slightly volatile
Total Assets14.1 B21.4 B
Way Down
Slightly volatile
Total Current Assets3.5 B4.7 B
Way Down
Slightly volatile
Total Cash From Operating Activities1.1 B1.5 B
Way Down
Slightly volatile

Zimmer Biomet Holdings F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Zimmer Biomet's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Zimmer Biomet in a much-optimized way.

About Zimmer Biomet Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Common Stock Shares Outstanding

164.88 Million

As of now, Zimmer Biomet's Common Stock Shares Outstanding is increasing as compared to previous years.

Zimmer Biomet ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Zimmer Biomet's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Zimmer Biomet's managers, analysts, and investors.
Environmental
Governance
Social

About Zimmer Biomet Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Zimmer Biomet Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zimmer Biomet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zimmer Biomet Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.41)
Dividend Share
0.96
Earnings Share
4.43
Revenue Per Share
37.807
Quarterly Revenue Growth
0.043
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.